Specifically, Lu et al. recently described a molecular mechanism by which VEGF blockade in glioblastoma cells causes enhanced tumor cell invasion through activation of the HGF receptor MET in a hypoxia-independent manner inducing a program reminiscent of epithelial-to-mesenchymal transition [6]. The gene discussed is MET; the disease is glioblastoma.